Bavarian Nordic has repeated a recommendation that its shareholders accept a takeover offer from an investment consortium, saying updated terms are "fair and attractive." The Danish biopharma company ...

The EMA's human medicines committee has recommended approval for Bavarian Nordic's chikungunya vaccine, which is shaping up to be the first alternative to a rival shot from Valneva. The CHIKV VLP ...